Dis-Chem’s Strategy Towards Healthcare Integration
Discover how Dis-Chem's strategy focuses on a culture shift to drive transformation and enhance its integrated healthcare approach.
Clicks Digital Push to Enhance Online Delivery Services
Healthcare and beauty retailer Clicks is embarking on a significant overhaul of its e-commerce platform. Its digital push aims to capitalise on growing home delivery demand and significantly improve customer convenience…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
Clicks Eyes Pharmacy Expansion and Earnings Growth
Clicks eyes pharmacy expansion with a 13.7% rise in earnings, driven by growth in its store network across South Africa.
Pharmacists Prescribe HIV Treatment and Enhance Care
Find out how trained pharmacists can now prescribe HIV treatment, revolutionizing access to antiretroviral therapy for patients.
Clicks Value Reaches New Heights in Retail Sector
Discover the impressive rise of Clicks value as it nears R100 billion, outpacing Dis-Chem in market valuation.
Dis-Chem Transforming Retail with Health Insurance
Dis-Chem is shaking up the health insurance market in South Africa with innovative strategies and services.
Counterfeit Medicine Crisis in South Africa’s Public Health System
South Africa is grappling with a quiet, yet deadly crisis: the alarming proliferation of counterfeit and substandard medicines, known as the counterfeit medicine crisis. While the nation faces ongoing health-care challenges like rising drug prices, medicine shortages, and a strained public health system, the influx of fake drugs presents a far more insidious threat. These…...
Dis-Chem Faces Challenges in a Competitive Market
Discover how Dis-Chem plans to regain market share with a revamped rewards programme designed for customer loyalty.
Clicks Interim Results Driven by Loyalty and Digital Sales
Read about the Clicks interim results that reveal a 13.2% rise in headline earnings per share and significant market achievements.
Clicks to sell stake in Unicorn Pharmaceuticals
Following a Constitutional Court ruling, Clicks Group plans to sell its shareholding in Unicorn Pharmaceuticals, enabling new pharmacy license applications.